ArticleFrontiers in medicine2026
Application of ultrasound-guided percutaneous catheter drainage in the treatment of tuberculous psoas abscesses.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the clinical utility of ultrasound-guided percutaneous catheter drainage (UPCD) in treating tuberculous psoas abscesses (TPA). Methods: A retrospective analysis was conducted on 114 cases of TPA with anti-tuberculosis chemotherapy at our institution. The patients were categorized into three groups based on their treatment modalities: preoperative UPCD combined with surgery (43 cases), surgery-only (39 cases), and UPCD-only (32 cases). Surgical debridement time and blood loss were compared between the preoperative UPCD combined with surgery group and the surgery-only group. Linear regression analysis was employed to evaluate the correlation between abscess volume and both debridement time and blood loss. Furthermore, recurrence and sinus tract formation were assessed across the groups during a 24-month follow-up period. Results: The preoperative UPCD combined with surgery group had significantly shorter debridement times and less blood loss compared to the surgery-only group (26.30 ± 4.14 min Conclusion: UPCD demonstrated substantial clinical value in the management of TPA. This approach not only reduced surgical time and blood loss but also provided a minimally invasive therapeutic option, especially when combined with anti-tuberculosis chemotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.